SILK vs. CSII, LUNG, INO, AXNX, TNDM, NARI, IRTC, ICUI, IART, and NVCR
Should you be buying Silk Road Medical stock or one of its competitors? The main competitors of Silk Road Medical include Cardiovascular Systems (CSII), Pulmonx (LUNG), Inovio Pharmaceuticals (INO), Axonics (AXNX), Tandem Diabetes Care (TNDM), Inari Medical (NARI), iRhythm Technologies (IRTC), ICU Medical (ICUI), Integra LifeSciences (IART), and NovoCure (NVCR). These companies are all part of the "surgical & medical instruments" industry.
Cardiovascular Systems (NASDAQ:CSII) and Silk Road Medical (NASDAQ:SILK) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.
86.6% of Cardiovascular Systems shares are held by institutional investors. 3.8% of Cardiovascular Systems shares are held by insiders. Comparatively, 3.9% of Silk Road Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Silk Road Medical has a consensus price target of $20.10, indicating a potential downside of 3.50%. Given Cardiovascular Systems' higher probable upside, analysts plainly believe Silk Road Medical is more favorable than Cardiovascular Systems.
Cardiovascular Systems has higher revenue and earnings than Silk Road Medical. Cardiovascular Systems is trading at a lower price-to-earnings ratio than Silk Road Medical, indicating that it is currently the more affordable of the two stocks.
Cardiovascular Systems has a net margin of -15.79% compared to Cardiovascular Systems' net margin of -29.02%. Silk Road Medical's return on equity of -15.39% beat Cardiovascular Systems' return on equity.
Cardiovascular Systems received 328 more outperform votes than Silk Road Medical when rated by MarketBeat users. Likewise, 61.93% of users gave Cardiovascular Systems an outperform vote while only 50.56% of users gave Silk Road Medical an outperform vote.
Cardiovascular Systems has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Silk Road Medical has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500.
In the previous week, Silk Road Medical had 3 more articles in the media than Cardiovascular Systems. MarketBeat recorded 3 mentions for Silk Road Medical and 0 mentions for Cardiovascular Systems. Cardiovascular Systems' average media sentiment score of 1.17 beat Silk Road Medical's score of -0.11 indicating that Silk Road Medical is being referred to more favorably in the news media.
Summary
Cardiovascular Systems beats Silk Road Medical on 9 of the 17 factors compared between the two stocks.
Get Silk Road Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SILK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Silk Road Medical Competitors List
Related Companies and Tools
